These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21518753)

  • 1. What are the costs of atrial fibrillation?
    Blomstrom Lundqvist C; Lip GY; Kirchhof P
    Europace; 2011 May; 13 Suppl 2():ii9-12. PubMed ID: 21518753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial fibrillation ablation: a cost or an investment?
    Kautzner J; Bulkova V; Hindricks G; Maniadakis N; Della Bella P; Jaïs P; Kuck KH
    Europace; 2011 May; 13 Suppl 2():ii39-43. PubMed ID: 21518748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac resynchronization therapy: a cost or an investment?
    Boriani G; Mantovani LG; Biffi M; Schalij MJ; Martignani C; Leclercq C; Bax JJ; Auricchio A
    Europace; 2011 May; 13 Suppl 2():ii32-8. PubMed ID: 21518747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioverter-defibrillators: a cost or an investment?
    Leyva F; Fernandez Lozano I; Morgan J
    Europace; 2011 May; 13 Suppl 2():ii25-31. PubMed ID: 21518745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remote monitoring: a cost or an investment?
    Burri H; Heidbüchel H; Jung W; Brugada P
    Europace; 2011 May; 13 Suppl 2():ii44-8. PubMed ID: 21518749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of atrial fibrillation in United States managed care organizations.
    Kim MH; Lin J; Hussein M; Kreilick C; Battleman D
    Adv Ther; 2009 Sep; 26(9):847-57. PubMed ID: 19768638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health economics and the European Heart Rhythm Association.
    Vardas P; Boriani G
    Europace; 2011 May; 13 Suppl 2():ii1-2. PubMed ID: 21518741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Device therapy and hospital reimbursement practices across European countries: a heterogeneous scenario.
    Boriani G; Burri H; Mantovani LG; Maniadakis N; Leyva F; Kautzner J; Lubinski A; Braunschweig F; Jung W; Lozano IF; Fattore G
    Europace; 2011 May; 13 Suppl 2():ii59-65. PubMed ID: 21518752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed.
    Boccuzzi SJ; Martin J; Stephenson J; Kreilick C; Fernandes J; Beaulieu J; Hauch O; Kim J
    Curr Med Res Opin; 2009 Dec; 25(12):2853-64. PubMed ID: 19916729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major complications have an impact on total annual medical cost of diabetes: results of a database analysis.
    Morsanutto A; Berto P; Lopatriello S; Gelisio R; Voinovich D; Cippo PP; Mantovani LG
    J Diabetes Complications; 2006; 20(3):163-9. PubMed ID: 16632236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and economic burden of suspected adverse events and adverse event monitoring during AF therapy.
    Kim MH; Lin J; Hussein M; Battleman D
    Curr Med Res Opin; 2009 Dec; 25(12):3037-47. PubMed ID: 19852699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacoeconomics of anticoagulation therapy for stroke prevention in atrial fibrillation: a review.
    Szucs TD; Bramkamp M
    J Thromb Haemost; 2006 Jun; 4(6):1180-5. PubMed ID: 16706956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
    Jahnz-Rózyk K; Targowski T; From S
    Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct costs of warfarin treatment among patients with atrial fibrillation in a Finnish health care setting.
    Hallinen T; Martikainen JA; Soini EJ; Suominen L; Aronkytö T
    Curr Med Res Opin; 2006 Apr; 22(4):683-92. PubMed ID: 16684429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of improving primary care treatment of late-life depression.
    Katon WJ; Schoenbaum M; Fan MY; Callahan CM; Williams J; Hunkeler E; Harpole L; Zhou XH; Langston C; Unützer J
    Arch Gen Psychiatry; 2005 Dec; 62(12):1313-20. PubMed ID: 16330719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation: what have recent trials taught us regarding pharmacologic management of rate and rhythm control?
    Reiffel JA
    Pacing Clin Electrophysiol; 2011 Feb; 34(2):247-59. PubMed ID: 21091736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives in multiple sclerosis health care: special focus on the costs of multiple sclerosis.
    Rotstein Z; Hazan R; Barak Y; Achiron A
    Autoimmun Rev; 2006 Oct; 5(8):511-6. PubMed ID: 17027884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The health and cost effects of substituting home care for inpatient acute care: a review of the evidence.
    Soderstrom L; Tousignant P; Kaufman T
    CMAJ; 1999 Apr; 160(8):1151-5. PubMed ID: 10234345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of radiofrequency ablation compared with other strategies in Wolff-Parkinson-White syndrome.
    Hogenhuis W; Stevens SK; Wang P; Wong JB; Manolis AS; Estes NA; Pauker SG
    Circulation; 1993 Nov; 88(5 Pt 2):II437-46. PubMed ID: 8222191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.